We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Bioventix plc (BVXP) Ordinary 5p

Sell:1,900.00p Buy:1,950.00p 0 Change: 400.00p (17.20%)
FTSE AIM 100:0.03%
Market closed |  Prices as at close on 27 October 2025 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:1,900.00p
Buy:1,950.00p
Change: 400.00p (17.20%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 27 October 2025 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:1,900.00p
Buy:1,950.00p
Change: 400.00p (17.20%)
Market closed |  Prices as at close on 27 October 2025 Prices delayed by at least 15 minutes | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Share news, reports & tips

  • China weakness sees profits fall for Bioventix

    27 October 2025 10:24

    (Sharecast News) - Bioventix reported lower annual profits on Monday, as weakness in its core markets, particularly China, offset gains from growing demand for its neurological diagnostic antibodies.

  • Revenue rises, profit falls for Bioventix

    31 March 2025 13:56

    (Sharecast News) - Bioventix reported a marginal rise in revenue for the six months ended 31 December on Monday, with profit before tax dipping slightly due to higher research and development expenditure.

  • Director dealings: Bioventix CFO raises stake

    31 October 2024 15:15

    (Sharecast News) - Bioventix revealed on Thursday that chief financial officer Bruce Hiscock had acquired 333 ordinary shares in the London-listed antibodies development and supply company.

  • BioVentix reports year of growth, warns of geopolitical risks

    28 October 2024 09:32

    (Sharecast News) - BioVentix, a UK-based developer of high-affinity monoclonal antibodies for clinical diagnostics, reported a 6% improvement in full-year revenue on Monday, to £13.6m, up from £12.82m in...

  • BioVentix revenue, earnings rise in first half

    25 March 2024 12:17

    (Sharecast News) - Monoclonal antibody specialist BioVentix reported a 13% rise in first-half revenue on Monday, to £6.7m, compared to £5.9m in the prior year.

  • Sunday share tips: Octopus Renewables Infrastructure Trust, Bioventix

    19 November 2023 21:24

    (Sharecast News) - The Financial Mail on Sunday's Midas column tipped the Octopus Renewables Infrastructure Trust to readers, pointing out its 7% dividend yield and the current valuation of its shares.

Company announcements Announcements


Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.

© Digital Look Ltd 1998-2025. All rights reserved.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.